203 related articles for article (PubMed ID: 34855554)
1. DEAD-box Helicase 27 Promotes Hepatocellular Carcinoma Progression Through ERK Signaling.
Xiaoqian W; Bing Z; Yangwei L; Yafei Z; Tingting Z; Yi W; Qingjun L; Suxia L; Ling Z; Bo W; Peng Z
Technol Cancer Res Treat; 2021; 20():15330338211055953. PubMed ID: 34855554
[No Abstract] [Full Text] [Related]
2. ERK pathway activation contributes to the tumor-promoting effects of hepatic stellate cells in hepatocellular carcinoma.
Xie YX; Liao R; Pan L; Du CY
Immunol Lett; 2017 Aug; 188():116-123. PubMed ID: 28668554
[TBL] [Abstract][Full Text] [Related]
3. HOXB7 promotes tumor progression via bFGF-induced activation of MAPK/ERK pathway and indicated poor prognosis in hepatocellular carcinoma.
Wang WM; Xu Y; Wang YH; Sun HX; Sun YF; He YF; Zhu QF; Hu B; Zhang X; Xia JL; Qiu SJ; Zhou J; Yang XR; Fan J
Oncotarget; 2017 Jul; 8(29):47121-47135. PubMed ID: 28454092
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of castor zinc finger 1 predicts poor prognosis and facilitates hepatocellular carcinoma progression via MAPK/ERK signaling.
Wang JL; Yang MY; Xiao S; Sun B; Li YM; Yang LY
J Exp Clin Cancer Res; 2018 Mar; 37(1):45. PubMed ID: 29506567
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA UBE2CP3 enhances HCC cell secretion of VEGFA and promotes angiogenesis by activating ERK1/2/HIF-1α/VEGFA signalling in hepatocellular carcinoma.
Lin J; Cao S; Wang Y; Hu Y; Liu H; Li J; Chen J; Li P; Liu J; Wang Q; Zheng L
J Exp Clin Cancer Res; 2018 Jun; 37(1):113. PubMed ID: 29866133
[TBL] [Abstract][Full Text] [Related]
6. MCM6 promotes metastasis of hepatocellular carcinoma via MEK/ERK pathway and serves as a novel serum biomarker for early recurrence.
Liu M; Hu Q; Tu M; Wang X; Yang Z; Yang G; Luo R
J Exp Clin Cancer Res; 2018 Jan; 37(1):10. PubMed ID: 29357919
[TBL] [Abstract][Full Text] [Related]
7. MiR-144-3p-mediated dysregulation of EIF4G2 contributes to the development of hepatocellular carcinoma through the ERK pathway.
Li S; Shao J; Lou G; Wu C; Liu Y; Zheng M
J Exp Clin Cancer Res; 2021 Feb; 40(1):53. PubMed ID: 33526055
[TBL] [Abstract][Full Text] [Related]
8. DEAD-box helicase 27 enhances stem cell-like properties with poor prognosis in breast cancer.
Li S; Ma J; Zheng A; Song X; Chen S; Jin F
J Transl Med; 2021 Aug; 19(1):334. PubMed ID: 34362383
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1 (EFEMP1) suppressed the growth of hepatocellular carcinoma cells by promoting Semaphorin 3B(SEMA3B).
Hu J; Duan B; Jiang W; Fu S; Gao H; Lu L
Cancer Med; 2019 Jun; 8(6):3152-3166. PubMed ID: 30972979
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of CSN6 promotes the epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma.
Xu M; Zhen L; Lin L; Wu K; Wang Y; Cai X
Clin Res Hepatol Gastroenterol; 2020 Jun; 44(3):340-348. PubMed ID: 31422034
[TBL] [Abstract][Full Text] [Related]
11. LncRNA DDX11-AS1 accelerates hepatocellular carcinoma progression via the miR-195-5p/MACC1 pathway.
Wan T; Zheng J; Yao R; Yang S; Zheng W; Zhou P
Ann Hepatol; 2021; 20():100258. PubMed ID: 32961346
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA LINC01503 promotes the progression of hepatocellular carcinoma via activating MAPK/ERK pathway.
Wang MR; Fang D; Di MP; Guan JL; Wang G; Liu L; Sheng JQ; Tian DA; Li PY
Int J Med Sci; 2020; 17(9):1224-1234. PubMed ID: 32547318
[No Abstract] [Full Text] [Related]
13. TANK-Binding Kinase 1 (TBK1) Serves as a Potential Target for Hepatocellular Carcinoma by Enhancing Tumor Immune Infiltration.
Jiang Y; Chen S; Li Q; Liang J; Lin W; Li J; Liu Z; Wen M; Cao M; Hong J
Front Immunol; 2021; 12():612139. PubMed ID: 33679751
[TBL] [Abstract][Full Text] [Related]
14. DEAD-box helicase 27 promotes colorectal cancer growth and metastasis and predicts poor survival in CRC patients.
Tang J; Chen H; Wong CC; Liu D; Li T; Wang X; Ji J; Sung JJ; Fang JY; Yu J
Oncogene; 2018 May; 37(22):3006-3021. PubMed ID: 29535419
[TBL] [Abstract][Full Text] [Related]
15. APN-mediated phosphorylation of BCKDK promotes hepatocellular carcinoma metastasis and proliferation via the ERK signaling pathway.
Zhai M; Yang Z; Zhang C; Li J; Jia J; Zhou L; Lu R; Yao Z; Fu Z
Cell Death Dis; 2020 May; 11(5):396. PubMed ID: 32457292
[TBL] [Abstract][Full Text] [Related]
16. KCNN4 promotes invasion and metastasis through the MAPK/ERK pathway in hepatocellular carcinoma.
Li QT; Feng YM; Ke ZH; Qiu MJ; He XX; Wang MM; Li YN; Xu J; Shi LL; Xiong ZF
J Investig Med; 2020 Jan; 68(1):68-74. PubMed ID: 31431469
[TBL] [Abstract][Full Text] [Related]
17. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition.
Huan HB; Yang DP; Wen XD; Chen XJ; Zhang L; Wu LL; Bie P; Xia F
J Exp Clin Cancer Res; 2017 Jun; 36(1):86. PubMed ID: 28646927
[TBL] [Abstract][Full Text] [Related]
18. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A.
Zhang Y; Tao R; Wu SS; Xu CC; Wang JL; Chen J; Yu YS; Tang ZH; Chen XH; Zang GQ
J Exp Clin Cancer Res; 2018 Jun; 37(1):116. PubMed ID: 29898761
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA HOTAIR promotes hepatocellular carcinoma progression by regulating miR-526b-3p/DHX33 axis.
Liu Z; Ouyang G; Lu W; Zhang H
Genes Genomics; 2021 Aug; 43(8):857-868. PubMed ID: 33843021
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-inducible gene 2 promotes the immune escape of hepatocellular carcinoma from nature killer cells through the interleukin-10-STAT3 signaling pathway.
Cui C; Fu K; Yang L; Wu S; Cen Z; Meng X; Huang Q; Xie Z
J Exp Clin Cancer Res; 2019 May; 38(1):229. PubMed ID: 31142329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]